CXCL8 and diabetic kidney disease: Thus, though a few studies reported no relationship between urine/serum CXCL8 and renal function in patients with T1D and microalbuminuria (137–140), there is substantial evidence warranting further exploration of the potential clinical benefit of CXCR1/2 inhibition in diabetic nephropathy.